Cargando…
2544. Population pharmacokinetic meta-analysis of BV100 in healthy subjects and renally impaired subjects
BACKGROUND: We recently identified rifabutin as having potent antibacterial activity towards Acinetobacter baumannii under nutrient limiting conditions. BV100 is the abbreviation for a novel intravenous formulation of rifabutin under development for the treatment of serious infections due to A. baum...
Autores principales: | Moss, Jon, Watts, Michael, Marc, Gitzinger, Kemmer, Christian, Husband, Lisa, Dale, Glenn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677904/ http://dx.doi.org/10.1093/ofid/ofad500.2161 |
Ejemplares similares
-
Pharmacokinetics (PK) of Eravacycline in Subjects with Renal or Hepatic Impairment Compared with Healthy Subjects
por: Horn, Patrick, et al.
Publicado: (2017) -
Pharmacokinetics of intravenous telavancin in healthy subjects with varying degrees of renal impairment
por: Worboys, Philip D., et al.
Publicado: (2015) -
Pharmacokinetics, Safety, and Tolerability of Intravenous Durlobactam and Sulbactam in Subjects with Renal Impairment and Healthy Matched Control Subjects
por: O’Donnell, John, et al.
Publicado: (2019) -
Pharmacokinetics of Cabotegravir in Subjects with Severe Renal Impairment
por: Parasrampuria, Ridhi, et al.
Publicado: (2017) -
Safety and pharmacokinetics of SPR206 in subjects with varying degrees of renal impairment
por: Bruss, Jon B., et al.
Publicado: (2023)